Commonly prescribed oral antibiotics are associated with an increased risk of serious cutaneous adverse drug reactions compared with macrolides, with sulfonamides and cephalosporins carrying the highest risk. ja.ma/3z4m2w9

JAMA Collection on E-Cigarette Use, Review of Obesity in Adolescents, Antibiotic Drug Reactions, and more. Listen to a summary of the September 3 issue of JAMA. ja.ma/3z4OQ7I

JAMA News in Brief: Study of Historic Famine Strengthens Link Between Prenatal Malnutrition and Type 2 Diabetes ja.ma/3AWhl80

A recent MMWR report applied data from the 2022 National Survey on Drug Use and Health to estimate the opioid cascade of care. Viewpoint by NIAID News Arwady, Delphin-Rittmon, and Volkow provide the implications for clinical practice. ja.ma/4e6iJDu

The associations between social media & worsening adolescent mental health are stacking, Dr. Vivek Murthy, U.S. Surgeon General Vivek Murthy said in a recent interview with JAMA EIC Kirsten Bibbins-Domingo, and that the cost of inaction was too high to delay. Read the interview. ja.ma/3XxR8WA

Among adults aged 60 years and older in 19 US states, RSV vaccination was associated with a reduced likelihood of hospitalization with RSV compared with no vaccination. ja.ma/3TfyakQ

Viewpoint discusses H5 influenza vaccine use in light of the current outbreak and how vaccine development, stockpiling, and deployment could shape the US response to future pandemics. ja.ma/3Tg6Lzo

JAMA Insights investigates the increased rates of climate change–related preventable injury and the importance of emergency and disaster preparedness as well as injury and violence prevention. ja.ma/4eep1kF

Viewpoint: bias exists in health care AI algorithms despite recent federal rules to prohibit discriminatory outcomes; MedStar Health authors recommend ways that health care facilities, AI developers, and regulators could address this bias. ja.ma/3ZbeIta

In this Viewpoint Joseph Palamar and Alex J Krotulski, PhD discuss the spread of medetomidine in the US illicit opioid market and the need for monitoring and a public health response. ja.ma/47b69AJ

Viewpoint discusses the high cost of new gene therapies for sickle cell disease, the challenges these costs pose for health care access, and new policy approaches to ensure fair reimbursement for payers and manufacturers. ja.ma/3ZcnRlt

This Medical News story examines the controversy surrounding the FDA’s first authorization of flavored e-cigarettes. ja.ma/3MvPdv0

Balloon angioplasty + aggressive medical management may be effective for symptomatic intracranial atherosclerotic stenosis, although risk of stroke or death within 30 days of balloon angioplasty should be considered in clinical practice. ja.ma/3TcBLzV

New CDC study: #RSV vaccines reduce the risk of RSV-associated hospitalization. RSV vaccines are recommended for all adults ages 75+ and for those ages 60-74 who are at increased risk for severe RSV. Read the full study in JAMA: bit.ly/4cVw0hk

Acute pericarditis is a common cause of nonischemic chest pain. This Review article examines the causes, treatments, and prognosis of both acute and recurrent pericarditis. ja.ma/3ziKNER

This study found that 78% of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and 29% with stage II PDAC with initial stages designated on preoperative imaging were upstaged on histopathology. ja.ma/4cWq5Zo

Plantar fasciitis is a common cause of heel pain among adults. This JAMA Patient Page describes the condition of plantar fasciitis and its diagnosis and treatment. ja.ma/3Xd2PAy

Most viewed in the last 7 days from JAMA: What is the long-term prognosis of myocarditis after COVID-19 mRNA vaccination and do clinical outcomes and medical management differ from myocarditis of other origins? ja.ma/3z83riG

Author Zhongrong Miao from Beijing Tiantan Hospital discusses the BASIS randomized clinical trial of balloon angioplasty for symptomatic intracranial atherosclerotic stenosis with JAMA Deputy Editor Christopher Muth. ja.ma/3XubJLh

Viewpoint: Authors from Brigham and Women's Hospital discuss initiatives designed to capture the value of public investment that will result in an accurate, comprehensive, and transparent paper trail of public funding. ja.ma/3B1sEvH